Generic Approvals Rebound as First Generics Don’t Keep Pace With 2016 or 2017

Generic Approvals Rebound as First Generics Don’t Keep Pace With 2016 or 2017

Source: 
RAPS.org
snippet: 

A lull in generic drug approvals (partially due to a new requirement) in January and February has not stopped the number of approvals from continuing to rebound in April and May, according to the US Food and Drug Administration’s (FDA) latest monthly tallies of generic statistics.